throbber
BERND GUTTE
`
`
`aemctete
`and Applications
`
`—
`
`Edited by
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`

`

`
`Peptides
`
`Synthesis, Structures,
`and Applications
`
`Edited by
`
`Bernd Gutte
`
`BiochemischesInstitut der Universitat Ztirich
`CH-8057 Ziirich, Switzerland
`
`aereeypuneyinesnanenenettinGititstkamemageeeneren=©~AtimmiiineniAtsimunnmnymengeeigot
`
`
`
`
`
`
`SoseemeeeneenopmnessraieinettonyempiHoe+:°eawe
`
`Academic Press
`San Diego
`NewYork
`
`Boston
`
`London
`
`Sydney
`
`Tokyo
`
`Toronto
`
`MPI EXHIBIT 1059 PAGE 2
`
`

`

`
`
`—ee,
`nnearnanemnenneetnnsa-—--hemmnememsentinesteeefsternum
`
`
`
`Cover art: Conformation of cyclosporin A observedin the crystal.
`See Chapter 5 by Marshall egal.
`
`This book is printed on acid-free paper.
`
`Copyright © 1995 by ACADEMIC PRESS,INC.
`
`All Rights Reserved.
`Nopart of this publication may be reproduced or transmitted in any form or by any
`means, electronic or mechanical, including photocopy, recording, or any information
`storage andretrieval system, without permission in writing from the publisher.
`
`Academic Press, Inc.
`A Division of Harcourt Brace & Company
`525 B Street, Suite 1900, San Diego, California 92101-4495
`
`United Kingdom Edition published by
`Academic Press Limited
`24-28 Oval Road, London NWI 7DX
`
`utte.
`
`Library of Congress Cataloging-in-Publication Data
`Peptides : synthesis, structures, and applications / edited by Bernd
`P.
`cm.
`Includes bibliographical references and index.
`ISBN 0-12-310920-5 (alk. paper)
`1. Peptides,
`2. Peptides--Synthesis.
`1. Gutte, Bernd,
`QP552.P4P487
`1995
`574.19'2456--de20
`
`3. Peptides--Structure.
`
`95-15417
`
`PRINTEDIN THE UNITED STATE
`S OF AMERICA
`95
`96
`97
`eh
`99
`00 BBO9
`8 7654321
`
`CIP
`
`MPI EXHIBIT 1059 PAGE3
`
`

`

`
`
`Contents
`
`Contributors
`
`Preface
`
`1
`The History of Peptide Chemistry
`Theodor Wieland
`
`Introduction
`I.
`Il. Early Peptide Syntheses
`III. A NewEra in Peptide Chemistry
`IV. Classic Peptide Syntheses
`V. Conclusion
`
`References
`
`2
`
`Amide Formation, Deprotection, and Disulfide Formation
`in Peptide Synthesis
`Yoshiaki Kiso and Haruaki Yajima
`
`I. Amide-Forming Reactions
`I]. Deprotection
`Ill. Disulfide Bond Formation
`
`Abbreviations
`
`References
`
`3
`Solid-Phase Peptide Synthesis
`Bruce Merrifield
`
`I.
`Introduction
`Il. The Solid Support
`
`xi
`
`xili
`
`26
`
`34
`
`34
`
`40
`
`53
`
`61
`
`82
`
`84
`
`94
`
`94
`
`v
`
`MPI EXHIBIT 1059 PAGE 4
`
`

`

`™e
`
`103
`114
`127
`137
`143
`146
`156
`159
`
`17]
`
`172
`
`175
`
`178
`
`183
`
`187
`
`188
`
`191
`
`193
`
`195
`
`209
`
`218
`
`225
`
`235
`
`Cc
`vi
`went
`Handles, Linkers, and Spacers
`Protecting Group Strategy
`The Coupling Reaction
`Cause and Correction of Incomplete Coupling Reactions
`The Cleavage Reaction
`Solid-Phase Synthesis of Peptides and Proteins
`Abbreviations
`
`Hl.
`
`IV.
`
`V.
`
`VI.
`
`VIL.
`
`Vill.
`
`References
`
`4
`a-Helix Formation by Peptides in Water
`J. Martin Scholtz and Robert L. Baldwin
`
`I,
`
`I.
`
`Ill.
`
`IV.
`
`V.
`
`VI.
`
`VII.
`
`Introduction
`Methodsof Studying Helix Formation
`Models for Helix—Coil Transition
`Helix Propensities
`Side-Chain Interactions
`Capping Interactions
`Protein Helices
`
`References
`
`5
`Peptide Conformation: Stability and Dynamics
`Garland R. Marshall, Denise D. Beusen, and Gregory V Nikiforovich
`
`l.
`
`II.
`
`III.
`
`IV.
`
`V.
`
`Introduction
`
`Theoretical Studies
`Experimental Analysis
`Goal-Directed Modifications of Conformational Flexibility
`Examples of Experimental and Computational Techniques
`Applied to the Study of Peptide Conformational Stability
`and Dynamics
`References
`
`MPI EXHIBIT 1059 PAGE 5
`
`

`

`
`
`
`
`Contents viiretts
`
`6
`Structure—Function Studies of Peptide Hormones:
`An Overview
`
`Victor J. Hruby and Dinesh Patel
`
`Introduction
`I.
`II. Mammalian Peptide Hormones
`Ill. Use of Classic Structure—Function Studies:
`General Considerations
`IV. Use of Conformational Constraints: General Considerations
`V. Selected ExamplestoIllustrate Approaches
`VI. Summaryand Conclusions
`References
`
`247
`248
`
`250
`252
`257
`277
`279
`
`7
`Neuropeptides: Peptide and Nonpeptide Analogs
`Andrzej W. Lipkowski and Damel B. Carr
`I. Biosynthesis of Neuropeptides
`II. Neuropeptide Receptors
`Ill. Opioids
`IV. Tachykinins
`V. Angiotensin II
`VI. Oxytocin and Vasopressin
`VII. Cholecystokinin
`VIH. Conclusions
`References
`
`8
`Reversible Inhibitors of Serine Proteinases:
`Naturally Occurring Miniproteins, Semisynthetic Variants,
`Recombinant Homologs, and Synthetic Peptides
`Herbert R. Wenzel and Harald Tschesche
`
`Introduction
`].
`Il. Serine Proteinase—Inhibitor Interactions
`III. Naturally Occurring Proteinase Inhibitors
`
`288
`289
`290
`297
`301
`305
`307
`310
`311
`
`322
`323
`325
`
`MPI EXHIBIT 1059 PAGE6
`
`
`
`is
`
`OELTTTTDIT
`
`aeopree
`“7G
`
`

`

`3
`IV. Semisynthetic Proteinase Inhibitors
`x
`V. Proteinase Inhibitors by Genetic Engineering
`VI. Chemically Synthesized Proteinase Inhibitors and Fragments *
`VII. Concluding Remarks and Outlook
`Ref
`ws
`eferences
`35
`
`9
`Design of Polypeptides
`Bernd Gutte and Stephan Klauser
`I.
`Introduction
`II. Recent Design Activities
`Ill. Polypeptide Design: Quo Vadis?
`References
`
`10
`
`Soluble Chemical Combinatorial Libraries:
`Current Capabilities and Future Possibilities
`Richard A. Houghten
`
`Introduction
`I.
`II. Classes and Applications of Soluble Combinatorial
`Libraries of Peptides
`Ill. Applications of Soluble Peptide Libraries
`IV. Conclusion
`References
`
`11
`Epitope Mapping with Peptides
`Hans RudolfBosshard
`
`Introduction
`I.
`II. The Nature of Epitopes
`Ill. Overview of Noncrystallographic Mapping Procedures
`IV. Cross-Reactivity Studies between Proteins and Peptides
`Using Antiprotein Antibodies
`V. Cross-Reactivity Studies between Proteins and Peptides
`Using Antipeptide Antibodies
`
`363
`366
`389
`399
`
`396
`
`401
`404
`414
`415
`
`419
`420
`425
`
`421
`
`4
`
`MPI EXHIBIT 1059 PAGE 7
`
`we
`
`

`

`
`
`
`
` Contents ix
`
`VI. Concluding Remarks
`References
`
`12
`Synthesis and Applications of BranchedPeptides
`in Immunological Methodsand Vaccines
`james P Tam
`
`Introduction
`I.
`Il. Types of Branched Peptides
`If]. Design and Physical Characteristics of Multiple
`Antigen Peptides
`IV. Multiple Antigen Peptide Immunogenicity
`V. Application of Multiple Antigen Peptides in Vaccines
`VI. Other Applications
`VII. Preparation of Multiple Antigen Peptides
`References
`
`Index
`
`450
`451
`
`456
`456
`
`458
`460
`469
`474
`477
`493
`
`501
`
`MPI EXHIBIT 1059 PAGE8
`
`
`
`

`

`
`
`
`
`
`
`
`Amide Formation, Deprotection, and
`Disulfide Formation in Peptide Synthesis
`
`Yoshiaki Kiso
`Department of Medicinal Chemistry
`Kyoto Pharmaceutical University
`Yamashina-ku, Kyoto 607, Japan
`
`Haruaki Yajima
`Niigata College of Pharmacy
`Niigata 950-21, Japan
`
`
`
`L Amide-Forming Reactions
`A. Acid Chloride and Fluoride Methods
`B. Active Ester Methods
`1. Phenyl Esters
`2. N-HydroxylamineEsters
`3. Bifunctional Active Esters
`C. Unsymmetrical Anhydride Methods
`1. Mixed Anhydride Method
`2. Phosphoric Mixed Anhydride Methods
`D. Carbodiimide Methods
`
`1. DCC-Additive Methods
`2. Fragment Condensation at Glycine or Proline
`Residues
`
`E. Azide Methods
`1. Protected Hydrazide Methods
`2. Azide Method Using Diphenylphosphorylazide
`F. Phosphonium and Uronium Salt Type Coupling
`Reagents
`G. Other Amide-Forming Reactions
`II. Deprotection
`A. Deprotection of a-Amino Protecting Groups
`1. Mild Acids
`
`2. Alkaline Conditions
`B. Final Deprotection
`1.
`tert-Butoxycarbonyl/ Benzyl]
`2. 9-Fluorenylmethoxycarbonyl /tert-Buty|
`3. OtherStrategies
`
`Pepuades:Synthesis, Structures, andApplications
`Copyright © 1995 by Academic Press, Inc. All rights of reproductionin any form reserved.
`
`39
`
`MPI EXHIBIT 1059 PAGE 9
`
`

`

`40
`
`Yoshiaki Kiso and Har
`
`lll. Disulfide Bond Formation
`A. Reduction—Reoxidation of Disulfide Bond-
`Containing Peptides and Proteins
`1. Examination of Oxidation Conditions
`2. Formation of Isomers
`B. Disulfide Formation by Air Oxidation
`1. Disulfide Formation by One-Step Deprotection
`2. Disulfide Formation by Two-Step Deprotection
`C. Disulfide Formation by lodine Oxidation
`D. Stepwise Disulfide Formation
`1. Combination of 4-Methylbenzyl and Acetamido-
`methyl Groups
`2. Combination of Trityl and Acetamidomethyl
`Groups
`3. Combination of 3-Nitro-2-pyridosulfenyl and
`Acetamidomethyl Groups
`E. Disulfide Formation by Silyl Chloride—Sulfoxide
`System
`1. Disulfide Bond Formation Using Sily! Chloride—
`Sulfoxide System
`2. Possible Mechanism
`3. Synthesis of Human Brain Natriuretic Peptide
`(hBNP)
`4. Directed Formation of Double Intrachain
`
`Disulfides
`
`5. Directed Formation of Double Interchain
`
`Disulfides
`6. Regioselective Formation of the Three Disulfide
`Bonds of Human Insulin
`Abbreviations
`
`References
`
`
`I. Amide-Forming Reactions
`The amide-formingreaction, or coupling reaction, is one of the most im-
`portant steps in peptide synthesis. Because harsh chemical conditions can dam-
`age complex peptides, appropriate activation is required to perform the coupling
`under mild conditions. Theoretically,
`two types of reactions are available.
`namely, aminoactivation and carboxylactivation. The former methods, howevel,
`have rarely been applied to practical peptide synthesis because of the drastic fe-
`action conditions and racemization. Carboxylactivation has been used in almost
`all the more recent peptide couplings. The general mechanism ofcarboxyl acti-
`vation is illustrated in Scheme 1, where X represents any kind of activating
`group or atom.
`
`MPI EXHIBIT 1059 PAGE 10
`
`

`

`pe
`
`
`
`2. Amide Formation, Deprotection, and Disulfide Formation 41es
`
`ie
`
`Ri—cx + NHp——R?0— a + HX
`sen
`i
`Scheme 1__Peptide bond formation by carboxylactivation.
`There are two possible synthetic strategies: stepwise elongation and frag-
`ment condensation. A synthetic scheme which employs either or both methods
`is elaborated accordingto the size and nature of the peptide to be synthesized. In
`stepwise elongation, each amino acid bearing an N*-amino protecting group is
`activated and coupled to the carboxyl-terminal amino acid one by one. This
`methodis usually applied to the synthesis ofrelatively small peptides or peptide
`fragments of a larger peptide. Fragment condensation is used to construct a
`larger peptide from two peptide fragments. The method, however, is often ac-
`companied by racemization unless appropriate care is taken. Antonovics and
`Young (1967) studied in detail
`the coupling reactions which proceeded via
`azlactone (oxazolone) formation after carboxyl activation (Scheme 2). From this
`result, it is clear that the carboxyl activation on an aminoacid residue other than
`glycine or proline produces a racemized peptide unless means to inhibit race-
`mization are provided.
`
`R3
`
`a) nucleophilic
`
`RI.
`
`asic
`
`H
`N
`

`
`R?
`
`-
`
`0
`
`fast” Wye |
`sykedhe“ES
`attack
`“te
`b) b
`NH)—R*ot
`rm
`AhMA,Uf “Mhy"on
`
`Scheme:2 Racemizationmechanismduringhagmencondensation.
`
`Stepwise elongation and fragment condensation methods have been devel-
`oped to circumvent the inevitable racemization. The latter methods, including
`the useful azide method, require distinctive practical considerations.
`
`A. Acid Chloride and Fluoride Methods
`
`The acid chloride method wasfirst introduced by E. Fischer (1903). Most
`acid chlorides are prepared by treating amino acids with PCI,, PCl,, SOCL,
`(Pizey, 1974; Matsuda et al., 1985), or (COCI),. Any side-chain hydroxyl,thiol,
`a8 well as amino groups should be protected during coupling. The carboxy]
`
`MPI EXHIBIT 1059 PAGE11
`
`

`

`Yoshiaki Kiso and Haruaki Yajin,
`42
`‘ggem
`
`<=
`
`group, however,is activated so strongly that some side reactionslimitthe appli.
`cation of this method.
`Acid chloride methods have been usedefficiently in coupling of aming
`acids bearing N*-protecting groups such as 9-fluorenylmethoxycarbony| (Fmoc:
`Carpino ef al., 1986) and 2-(triphenylphosphino)ethyloxycarbonyl (Peoc; Kunz
`and Bechtolsheimer, 1982) which are stable under acidic conditionsandcleay.
`able under alkaline conditions. The stability of the protecting groups to acidic
`conditions madeit possible to survive conversion to an acid chloride.
`Aminoacid fluorides used for solution and solid-phase synthesesare ob.
`tained by treatment with cyanuric fluoride (Bertho et al., 1991; Carpinoetal,
`1991) under mild conditions.
`
`B. Active Ester Methods
`
`The characteristics of the active ester method are as follows: (i) Twopath-
`ways of aminolysis are possible in the mixed anhydride method, whereas only
`one is found in the active ester method. (ii) The active ester can be stored.(iii)
`The ester can be coupled with an amine component that has free carboxy!
`groups. (iv) The method is especially useful for the synthesis of glutamine-
`and/or asparagine-containing peptides (Bodanszky and du Vigneaud, 1959). The
`side product generated on carboxy! activation, a nitrile derivative, can be elimi-
`nated by purification.
`Active esters are usually prepared by the dicyclohexylcarbodiimide (DCC)
`or mixed anhydride method from N-protected amino acids and alcohol. Trans-
`esterification methods using trifluoroacetate (Sakakibara and Inukai, 1965; Rze-
`szotarska and Vlasov, 1967) and trichloroacetate (Fujino and Hatanaka, 1968)
`have also been reported.
`
`I. Phenyl Esters
`Generally, phenols which have electron-withdrawing substituent in the
`ortho or para position can be used as active esters (Wieland and Jaenicke, 1956;
`Wieland et al., 1962). In practice, however, p-nitrophenol (Bodanszky, 1955;
`Bodanszkyet al., 1957), 2,4,5-trichlorophenol (Pless and Boissonnas, 1963a,b,c;
`Guttmannet al., 1965; Strumer etal., 1965; Huguenin, 1964), pentachlorophe-
`nol
`(Kovacs and Ceprini, 1965; Kovacs et al., 1967a; Kupryszewski and
`Formela, 1961), and pentafluorophenol (Kovacs et al., 1967b) are widely used
`becauseoftheir easy availability.
`After the coupling reaction with a phenol-type active ester, the liberated
`acidic phenol must be removed by an appropriate method such as washing
`with aqueous sodium carbonate or recrystallization. If the desired peptide
`productis an oil, the phenol cannot be removed completely. Water-soluble ac-
`tive esters, such as 4-hydroxyphenyldimethylsulfonium methylsulfate (Kougé
`et al., 1986; 1987), overcomethese difficulties not only by allowing easy fe
`moval of the by-products, but also by undergoing the reaction in aqueous sol-
`
`MPI EXHIBIT 1059 PAGE 12
`
`

`

`
`
`2, Amide Formation, Deprotection, and Disulfide Formation 43rrr
`
`vents. It is noteworthy that an active ester acylates the phenolic hydroxyl
`group on tyrosine in the presence of a base (Agarwaler al., 1969; Ramachan-
`dran and Li, 1963).
`
`2. N-HydroxylamineEsters
`A series of N-hydroxylamine-type active esters represented by N-hydroxy-
`succinimide (HOSu) ester (Anderson et al., 1963; 1964) have been described.
`These types of active esters are regarded as bifunctional active esters which
`rarely induce racemization of the a-carbon atom. In contrast to the above phenol
`esters, these esters eliminate N-hydroxylamine after coupling, which is easily
`soluble in water and thus removable by simple washing.
`HOSu esters are prepared by coupling N-protected amino acids and
`HOSu by DCC. An undesired side reaction was reported to take place during
`the preparation (Gross and Bilk, 1968; Weygandet al., 1968): the binding of
`DCC and HOSuproduces B-alanine via Lossen rearrangement (Scheme3). N-
`Hydroxy-5-norbornene-2,3-dicarboximide (HONB,1 in Fig. 1) introduced by
`Fujino et al. (1974), rarely undergoes suchside reactions because ofits rigid
`structure.
`
`d bcc
`
`N-OH

`
`okdso
`bon LO
`(0
`(NI
`NQ “Aee
`
`H
`
`AT
`
`oo
`
`n:—U-cH,-CH,-0-0~Su
`
`|
`
`oOll
`
`=C=N-CH,-CH,-C-O—Su
`
`ll
`H
`|
`R-NH2
`il
`Su~O-C—8-Ala-NH-R—_————_SuO—C—N-CH,.-CH,-C-O—Su
`
`Scheme3_Side reaction on reacting HOSu with DCC.
`
`B-Ala
`
`| HOSu
`
`N-Hydroxybenzotriazole (HOBt, 2 in Fig. 1; K6nig and Geiger, 1970a,b)
`esters are widely used in peptide synthesis and are prepared using DCC. The
`racemization-suppressing effect and coupling accelerating effect of HOBtare
`excellent. Many groups have reported the reaction mechanism involving HOBt
`ester (Horiki, 1977; Konig and Geiger, 1973). The effects of HOBt as an addi-
`tive are described in a later section (D.1.). 3-Hydroxy-4-oxo-3,4-dihydro-1 ,2,3-
`benzotriazine (HOOBt, 3 in Fig. 1; Konig and Geiger, 1970c) is a reagent supe-
`nor to HOBt with regard to racemization. However, HOOBt esters have the
`disadvantage of undergoing Lossen rearrangement.
`
`MPI EXHIBIT 1059 PAGE 13
`
`

`

`44
`
`HO
`N
`N
`\
`
`Q
`
`HO—N
`
`0
`
`(1)
`
`~
`
`Yoshiaki Kiso and Haruakiy,.ij
`j
`
`HO
`
`N
`Nay
`
`(2)
`
`(3)
`
`Figure 1 Structures of HONB(1), HOBt(2), and HOObt(3).
`
`3. Bifunctional Active Esters
`Various bifunctional active esters such as hydroxyquinoline (HOQ,4 in F;
`2; Jakubke, 1965; Jakubke and Voigt, 1966a,b), catechol (5 in Fig. 2, Lloyd ang
`Young, 1968, 1971), and hydroxypyridine (6 in Fig. 2; Taschner et al., 1965ap)
`have been developed as racemization-free reagents for peptide fragment coupling
`They can, of course, be applied to coupling by stepwise elongation and are readily
`removable after the reaction, taking advantage oftheir bifunctionality.
`
`C. Unsymmetrical Anhydride Methods
`1, Mixed Anhydride Method
`The mixed anhydride method of peptide bond formation involves aminoly.
`sis of an anhydride consisting of an N-protected amino acid and another acid
`(Albertson, 1962; Meienhofer, 1979). The carboxylic—carboxylic mixed anhy-
`dride method and carbonic-carboxylic mixed anhydride methods were devel-
`oped. Isobutychloroformate (Vaughan and Osato, 1951) is commonlyused for
`the preparation of carbonic—carboxylic mixed anhydrides (Scheme4).
`
`Oo
`.
`NHR?
`4
`RO-COC
`R'—COO"EN’ —e RI ou R'--CO-NH—R? + ROH + CO,
`0
`tees.
`R—o-—c ™—R—0-CO-NH—A? Soyproduc)
`
`Xo
`
`R = isodulyl
`Scheme 4 Mixed anhydride method using isobutylchloroformate.
`
`N |
`
`HO
`
`HO
`
`HO
`
`N
`
`OH
`
`Figure 2
`
`(6)
`(5)
`(4)
`Structures of HOQ (4), catechol(5), and hydroxypyridine (6).
`
`MPI EXHIBIT 1059 PAGE 14
`
`‘
`
`

`

`
`
`a
`
`
`2, Amide Formation, Deprotection, andDisulfide Formation 452,Amide
`
`
`
`Formation,Deprotection,andDisulfideFormation49
`
`the amide-forming reaction is complete
`In mixed anhydride methods,
`within several minutes in an ice bath. The side-chain functional groups in the
`carboxyl component should be protected. The carboxyl groups in the amine
`component could be either in ester form orprotected tentatively with a tertiary
`amine. In the latter case, the reaction can be performed in water-containing sol-
`vents, but the product should be carefully separated becauseofits acidity.
`Asa side reaction in mixed anhydride methods, urethane formation occurs
`in the amine component (Albertson, 1962; Wieland et al., 1962; Wieland and
`Stimming, 1953), but it can be neglected under usual experimental conditions.
`Addition of HOBtto the reaction mixture before the amine componentis added
`reduces urethane formation (Prasad et al., 1985). Also, when Z-Gly (where Z
`represents the benzyloxycarbonyl group) is used as the carboxyl component,at-
`tention must be paid to the spontaneous formation of acylimide (Kopple and
`Renik, 1958; Schellenberg and Ullrich, 1959).
`Mixed anhydridesare also obtained by the reaction of amino acids and di-
`hydroquinoline derivatives. On reaction with a carboxyl component, 1-ethoxy-
`carbony]-2-ethoxy-1,2-dihydroquinoline (EEDQ; Belleau and Malek, 1968) or
`1-isobutyloxycarbonyl-2-isobutyloxy-1,2-dihydroquinoline (IIDQ; Kiso and Ya-
`jima, 1972; Kisoet al., 1973) is converted via a six-membered ring intermediate
`to quinoline and a carbonic—carboxylic mixed anhydride which immediately re-
`acts with an amine componentto give a peptide in good yield (Scheme 5). The
`by-products are carbon dioxide and quinoline as long as undesired urethane for-
`mation is negligible.
`
`R'-COOH
`
`R'-CO-NH-R?
`
`COOR
`oD OSo-F _NHyR? CO, ROH
`orar a
`n2
`
`=ethyl or isobutyl
`
`Scheme 5 Mixed anhydride method using EEDQ or IIDQ.
`
`2. Phosphoric Mixed Anhydride Methods
`The mixed anhydrides of amino acid and phosphoric acid are also useful
`for formation of the peptide bond. Manykinds of phosphoric reagents, for exam-
`ple, (PhO),P(O)CI (Albertson, 1962; Meienhofer, 1979) and Me,P(S)CI (Uekier
`al., 1979; 1988; Ueki and Inazu, 1982), have been developed. In this cate-
`gory, 3,3’-(chlorophosphoryl)bis(1,3-oxazolidin-2-one) (BOP-Cl, 7 in Fig. 3;
`Mesegueref al., 1980; Cabre and Palomo, 1984; Omodei-Sale et al., 1984) is
`particularly useful for coupling of imino acids (Van Der Auwera and Anteunis,
`1987; Tung et al., 1986) such as N-methyl amino acids (Tung and Rich, 1985)
`because of the strong reactivity and selectivity toward the amine component.
`Norborn-5-ene-2,3-dicarboximido diphenyl phosphate (NDPP,8 in Fig. 3)
`is a reagent for the so-called active ester-type mixed anhydride method (Kiso et
`
`MPI EXHIBIT 1059 PAGE 15
`
`

`

`
`
`46
`
`Yoshiaki Kiso and Haruak;Yajma
`
`
`
`(7)
`
`(8)
`
`Figure 3 Structures of BOP-CI (7) and NDPP(8).
`
`al., 1980a). In the reaction of NDPP and an amino acid, the HONBesterjs
`formed via a carboxylic-phosphoric mixed anhydride intermediate (Fig.3),
`
`D. Carbodiimide Methods
`
`N,N’-Dicyclohexylcarbodiimide (DCC) has been widely used (Rich and
`Singh, 1979; Williams and Ibrahim, 1981) since Sheehan and Hess (1955)first
`applied it to peptide synthesis. The reaction mechanism involving DCCisillus-
`trated in Scheme 6 (Schiissler and Zahn, 1962; Detar et al., 1966). Briefly, an
`activated intermediate, O-acylisourea, which is produced by reaction of a pro-
`tected amino acid and DCC, undergoes aminolysis to form a peptide anddicy-
`clohexylurea (DCU). The reaction of an N-protected amino acid and DCCwith-
`out an amine component gives another activated species, a symmetrical
`anhydride, which also reacts with amine components. The DCU produced in
`this reaction is insoluble in almost all commonorganic solvents andis thuseas-
`ily removed from the reaction mixture by filtration.
`
`R'-CO-0
`R-—N=C—NH-R
`,” (acylisourea) \
`
`————> R’-C0-NH-R?
`NH>-R2
`
`R'.COOH
`
`
`R—-N==C==N—R
`(DCC)
`
`
`
`
`
`
`,
`
`R'-COOH
`
`
`
`1R
`
`ICO.
`7°
`R'-CO
`
`R'CcO
`R-NH-CO—N-R
`
`(acylurea)
`
`
`
`recycled
`
`Scheme 6_Reaction mechanism of DCC.
`
`The noticeable side reaction is the formation of an acylurea by intramolec-
`ular rearrangement of the acylisourea. The extent of the side reaction is ef
`hanced when the proton concentration of N-protected aminoacid is decreased
`by excess triethylamine (which is usually used for neutralization of chloride ions
`boundto the amine component). The side reaction is profoundly influenced by
`
`MPI EXHIBIT 1059 PAGE 16
`
`

`

`
`
`2, Amide Formation, Deprotection, and Disulfide Formation 47ar
`
`the choice of solvent as well as the base (Sheehan et al., 1956). In the fragment
`condensation by DCC,this side reaction has to be considered seriously, but in
`the coupling of N-protected aminoacids,it can be ignored because of its easy
`removalby recrystallization. Dehydration of the side-chain amidegroup ofglut-
`amine or asparagine also occurs during DCCactivation.
`To simplify the removal of DCU and unreacted carbodiimide, water-sol-
`uble carbodiimides such as 1-ethyl-3-(3’-dimethylaminopropyl)carbodiimide
`were developed; in such systems,both the reagentand the resulting urea deriv-
`ative are soluble and easily removable by washing (Sheehan ef al., 1961).
`Diisopropylcarbodiimide (DIPCDI)is a useful reagent in solid-phase peptide
`synthesis (SPPS) because the diimide and the corresponding urea are soluble
`in organic solvents (Sheehan and Hess, 1955; Sheehan and Yang, 1958).
`
`1, DCC-Additive Methods
`Wiinsch’s group found that fragment condensation using DCC and HOSu
`under strictly controlled conditions preserves the chiral purity almost com-
`pletely, with less than 1% racemization being reported (Weygand et al., 1966;
`Wiinsch and Drees, 1966). The method wasapplied to the synthesis of glucagon
`to obtain an active peptide (Wiinsch, 1967; Wiinsch and Wendlberger, 1968;
`Wiinsch et al., 1968). Strictly speaking, however, the synthesis was carried out
`with suppression of racemization, and an accurate racemization test is required
`to judge whether the product is absolutely optically pure.
`The disadvantage of the DCC-HOSu method is the side reaction, Lossen re-
`arrangement, which gives a B-alanine derivative by reaction with amine compo-
`nents (Gross and Bilk, 1968; Weygand et al., 1968). To remedy this, Kénig and
`Geiger (1970a,b,c) examined various analogous reagents and reported DCC-HOBt
`as the most suitable. This reagent suppresses not only racemization but also acy-
`lurea formation in fragment condensation. In these syntheses, use of water-soluble
`carbodiimide instead of DCC was recommended (Kimura et al., 1981, 1988), as the
`urea or acylureas formed are more easily removed from the reaction products.
`These methodsarealso useful for the coupling of amino acids with respect
`to increases in yield and suppression of side reactions. The suppression of
`racemization by this methodology has been reported by many researchers using
`various additives (Yajimaet al., 1973a,b; Fujino, 1976). However, the racemiza-
`tion test is carried out in a model system, and the results do not always agree
`with practical synthesis.
`
`2. Fragment Condensationat Glycine or Proline Residues
`Activation of glycine residues does not cause racemization because
`glycine has no chiral center, nor does activation of proline residues because pro-
`line has no imino hydrogen which would participate in azlactone formation.
`Therefore, whatever kind of coupling method is used, fragment condensation by
`activating the carboxy! group ofglycine or proline neverfails to preserve chiral
`
`MPI EXHIBIT 1059 PAGE 17
`
`
`
`

`

`48
`
`Yoshiaki Kiso and HaruakiYajin,
`
`purity of the peptide, and these tactics are commonly usedin synthetic Schemes
`for larger peptides. When DCC is used as a coupling reagent in fragment con.
`densation, however, acylurea formation becomes a problem. The removal ofacy.
`lurea is fairly difficult. The addition of racemization-suppressing reagents Such
`as N-hydroxysuccinimide also suppresses acylurea formation.
`More recently, coupling reagents such as benzotriazole-1-yloxytris(dimetp.
`ylamino)phosphonium hexafluorophosphate (BOP) have been employedinsteag
`of DCC (Castro et al., 1975, 1977). The strong reactivity of the coupling reagent,
`is advantageousfor fragment condensation, since the reaction rate is slowerthay
`that of amino acid coupling. In addition, 4-(dimethylamino)pyridinecan be useq
`as a catalyst because of the lack of the problem of racemization at Gly or Pro
`residues.
`
`E. Azide Methods
`
`is currently
`The azide method, first developed by Curtius (1902, 1904),
`used not only for the stepwise coupling of troublesome aminoacids suchas ser-
`ine orhistidine, but also for fragment condensation, where it showsreal merit. It
`is the most suitable method for fragment condensation because little racemization
`occurs, and side-chain protection can be kept at a minimum (only the e-amino
`group of lysine and the thiol group of cysteine have to be protected) because
`azideis less reactive with side-chain functional groups such as hydroxyl groups.
`First, the hydrazide is prepared by treating an N-protected aminoacid or
`peptide ester with excess hydrazine hydrate. The hydrazide is convertedto azide
`by tert-butyl or isoamyl nitrite (Rudinger’s variation; Honzl and Rudinger,
`1961), and the azide reacts with the amine component withoutextraction with
`organic solvent. Because the azide is unstable at room temperature, the reaction
`with the amine componentis carried out below 0°C for 40 hr after neutralization
`of hydrogen azide with a base such as triethylamine or N-methylmorpholine.
`The resistance to racemization in this method is explained by theelectron
`distribution of the N, group, which reducesthe tendency of the R-CO—NHgroup
`to participate in azlactone formation (Scheme 7). However, using an isotope dilu-
`tion assay, Kempetal. (1970) detected racemization evenin the azide method.
`
`
`
`® ©
`RONO
`R'CO-NHCHA?CO-NHNH, ———» RICO-NHCHR2CO-N==N==N
`
`0
`R?
`oO
`Re
`NH,-R?
`od
`le — Hi
`—», et!
`N—CH—C—N
`@N—CH—C—N
`1_f
`\.@
`4
`\
`R So
`© Pa
`Ri—C
`N
`\
`/
`0 R°—NH, N
`PR?—NH—NH
`
`——> R'CO-NHCHR?CO—NHR?
`
`Scheme 7
`
`Suppression of racemizationof azide.
`
`MPI EXHIBIT 1059 PAGE 18
`
`

`

`
`
`2, Amide Formation, Deprotection, and Disulfide Formation 49AALreneetnrenrryemnnetpyrerrerereveraasernannaenepayvtt
`
`
`
`Theside reactionsthat generally occurin the azide procedureare as follows:
`(i) Curtius rearrangementat higher temperature, producing a urea derivative or an
`amine (Hofmann etal., 1960) (Scheme8), and (ii) hydrolysis of azide, giving an
`amide and nitric oxide (Honzl and Rudinger, 1961). In addition, side reactions
`which involve particular amino acids have also been reported (Gregory etal.,
`1968). In conclusion, the azide procedure is an excellent coupling method; how-
`ever, some side reactions have been reported, and the procedure is not simple.
`
`$-
`oO
`heat
`5/
`RG st —- R—N=C=0
`\oyen=n 7 Ne
`
`R—NH--CO—NH—R’
`WA _
`NHo—R
`\we
`
`R—NH—COOH ~—» R—NH,
`Scheme 8—Curtius rearrangementof azide.
`
`1, Protected Hydrazide Methods
`Peptide esters containing Arg(NO,), Asp(O-t-Bu), Asp(OBzl), or Glu(OBzl)
`(where t-Bu and Bzl represent tert-butyl and benzyl, respectively) cannot be con-
`verted to the corresponding hydrazide by hydrazinolysis. In such cases, a protected
`hydrazide is introduced at the C terminus of a peptide or carboxyl group of an
`amino acid. After elongation ofthe peptide chain, the substituent on the hydrazide
`is removed, and the resulting hydrazide is converted to an azide.
`Various protected hydrazides have beenreported. Naturally, the substituent
`chosen has to have a selectivity of removal different from that of the a-
`amino protecting group. The usual protecting groups for hydrazine are Z (Hof-
`mann ef al., 1950, 1952), tert-butoxycarbonyl (Boc; Boissonnas et al., 1960;
`Schwyzer et al., 1960), 2,2,2-trichloroethyloxycarbony] (Troc; Yajima and Kiso,
`1971; Watanabe et a/., 1974), and 2,2,2-trichloro-tert-butoxycarbonyl (Tcboc;
`Shimokura er al., 1985).
`
`2, Azide Method Using Diphenylphosphorylazide
`Azides have long been obtained exclusively via hydrazides since their
`first preparation by Curtius. Shioiri et al. (1972), however, devised an inter-
`esting alternative to the hydrazide-mediated azide method, and reported that
`
`of
`CHs—O,§
`DoNg
`TN¢\-0 C2Hs—-O
`
`
`0
`
`(9)
`
`(10)
`
`Figure 4
`
`Structures of DPPA (9) and DEPC (10).
`
`MPI EXHIBIT 1059 PAGE 19
`
`

`

`Yoshiaki Kiso and Haruakiyt aiiby
`Cigi?
`PN
`N’ O-N’
`Veo©
`
`N
`
`PF,
`(12)
`
`)
`
`—_
`
`(en
`N=C
`y
`7
`O-N"'N
`Prem
`
`(15)
`
`50
`
`Ny
`
`“N
`
`14
`
`s NeN
`oN
`:
`“N ‘O-N’
`
`PFO
`(11)
`
`\
`
`ar C)
`—
`‘ed * @N
`YO-N'
`IN cor =
`[
`‘O-N
`no O
`J
`
`(13)
`
`(14)
`
`b
`
`HO-N*
`
`°N
`
`Ny
`\vy
`
`No
`\8 2
`UN,
`N-C
`PFO vs
`
`‘O-N7
`
`°N
`
`[
`
`(16)
`
`(17)
`
`Figure 5 (a) Structures of BOP (11), PyBop (12), HBTU (13), TOPPipU (14), and BOI(15),
`(b) Structures of HOAt (16) and HATU (17).
`
`diphenylphosphorylazide (DPPA, 9 in Fig. 4) directly converts a free carboxy!
`group to an azide (Shioiri and Yamada, 1974). The coupling reaction is consid-
`ered to proceed via an azide rather than an acyloxyphosphoric mixed anhydrie,
`whichisalsoa likely intermediate. A similar reagent, diethylphosphorocyanidate
`(DEPC, 10 in Fig. 4) was also reported (Yamadaet al., 1973; Shioiri et al.
`1976a,b). The advantagesof the reaction using DPPA or DEPCare noformation
`of insoluble by-products and less racemization in fragment condensation.
`
`F. Phosphonium and Uronium Salt Type Coupling Reagents
`Very high performance of coupling reagents has been foundto be neces
`sary, especially in the field of SPPS. Benzotriazole-1-yloyxtris(dimethylamin0)
`phosphonium hexafluorophosphate (BOP,11 in Fig. 5a), reported by Castro ¢
`al. (1975, 1977), is an excellent coupling reagent offering high reactivity #
`easy handling. The reaction between BOP and an N-protected amino acid
`proceeds via an acyloxyphosphonium as an intermediate to producethe corres
`ponding benzotriazole ester and easily removable by-products such as her
`amethylphosphoric triamide (HMPA)and salts (Scheme 9a). Underbasic condi:
`tions, no side reaction accompanies the main reaction, in contrastto the ust °
`DCC,andthe reaction rate is generally very fast. For example, in the cas¢ °
`
`MPI EXHIBIT 1059 PAGE 20
`
`

`

`sone
`\ ow
`
`
`ee tee
`TR eee7
`
`\1
`
`
`
`2, Amide Formation, Deprotection, and Disulfide Formation 512,AmeeaecisultideFormationOT
`
`
`
`coupling of Boc-Ie with Val-OBzl, the reaction is completed within a few min-
`utes. BOPis used in both solution and solid-phase syntheses.
`However, HMPA,the starting material in the synthesis and a by-product in
`the reaction of BOP, has been reported to have respiratory toxicity. It is therefore
`recommended to replace BOP by benzotriazole- | -yloxytrispyrrolidinophospho-
`nium hexafluorophosphate (PyBOP, 12 in Fig. 5a), which has similar reactivity to
`BOP and forms no carcinogenic by-products (Martinez er al., 1988: Coste et al.,
`1990a).
`2-(1H-Benzotriazole-!-yl)-oxy-1,1 ,3,3-tetramethyluronium hexafluorophos-
`phate (HBTU, 13 in Fig. 5a; Knorr et al., 1989), 2-[2-oxo-1(2H)-pyridyl)-1,1,3,3-
`bispentamethyleneuronium tetrafluoroborate (TOPPipU,14 in Fig. 5a; Henklein et
`al., 1991), and 2-(benzotriazole-1-yl)-oxy-1 ,3-dimethylimidazolidinium hexafluo-
`rophosphate (BOI, 15 in Fig. 5a; Kiso et al., 1992b) have similar reactivities to
`BOP. Phosphoniumis substituted by uronium in these reag

This document is available on Docket Alarm but you must sign up to view it.


Or .

Accessing this document will incur an additional charge of $.

After purchase, you can access this document again without charge.

Accept $ Charge
throbber

Still Working On It

This document is taking longer than usual to download. This can happen if we need to contact the court directly to obtain the document and their servers are running slowly.

Give it another minute or two to complete, and then try the refresh button.

throbber

A few More Minutes ... Still Working

It can take up to 5 minutes for us to download a document if the court servers are running slowly.

Thank you for your continued patience.

This document could not be displayed.

We could not find this document within its docket. Please go back to the docket page and check the link. If that does not work, go back to the docket and refresh it to pull the newest information.

Your account does not support viewing this document.

You need a Paid Account to view this document. Click here to change your account type.

Your account does not support viewing this document.

Set your membership status to view this document.

With a Docket Alarm membership, you'll get a whole lot more, including:

  • Up-to-date information for this case.
  • Email alerts whenever there is an update.
  • Full text search for other cases.
  • Get email alerts whenever a new case matches your search.

Become a Member

One Moment Please

The filing “” is large (MB) and is being downloaded.

Please refresh this page in a few minutes to see if the filing has been downloaded. The filing will also be emailed to you when the download completes.

Your document is on its way!

If you do not receive the document in five minutes, contact support at support@docketalarm.com.

Sealed Document

We are unable to display this document, it may be under a court ordered seal.

If you have proper credentials to access the file, you may proceed directly to the court's system using your government issued username and password.


Access Government Site

We are redirecting you
to a mobile optimized page.





Document Unreadable or Corrupt

Refresh this Document
Go to the Docket

We are unable to display this document.

Refresh this Document
Go to the Docket